Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2021
Lyell appoints Richard Sherry as senior vice president
Lyell Immunopharma announced Richard Sherry's appointment as Senior Vice President, TIL Specialist and Clinical Lead.
2020
Sonoma Biotherapeutics raises $40 million in Series A funding
Sonoma Biotherapeutics launched with $40 million in Series A financing from an investor syndicate that included Lyell Immunopharma, ARCH Venture Partners, Milky Way Ventures and 8VC.
2020
Sonoma Biotherapeutics and Lyell Immunopharma enter strategic partnership
Sonoma Biotherapeutics entered into a strategic partnership with Lyell Immunopharma, providing both parties access to technologies and know-how to enhance cell therapies in their respective areas of focus.